Neuronetics, Inc. — Form SCHEDULE 13D/A
Filed August 4, 2026 · analyzed by the Ownership Agent
SCHEDULE 13D/A
▲ Likely positive
significance 28/100
What the filing says
Jorey Chernett (Pointillist Family Office), Neuronetics' second-largest shareholder, purchased 35,000 shares at weighted average price of $1.78/share (totaling ~$62.3K) on 7/14/2026. Concurrently, Chernett reached an 'Understanding' with the Board confirming comfort in management and capital position; Chernett will have opportunity to recommend a newly appointed board member. Largest shareholder Madryn Asset Management reaffirmed conviction in long-term value. No hostile action; constructive alignment framework announced.
Why this rating
Share purchase (~$62K) is <0.05% of $129M market cap—immaterial. Board seat opportunity is symbolic alignment, not operational change. Removes activist friction; no material strategic shift disclosed.
See more from August 4, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.